Publications by Leonardo Filipe Lemos Rocha

How Vibrio cholerae adapts to the environment: from cell shape transitions to antagonistic behavior

The bacterium Vibrio cholerae is the causative agent of the diarrheal disease cholera, which affects millions of people every year. Apart from being a human pathogen, V. cholerae is also a common member of aquatic habitats. Whilst the mechanism that allow ...

EPFL2022

The VarA-CsrA regulatory pathway influences cell shape in Vibrio cholerae

Melanie Blokesch, Leonardo Filipe Lemos Rocha

Despite extensive studies on the curve-shaped bacterium Vibrio cholerae, the causative agent of the diarrheal disease cholera, its virulence-associated regulatory two-component signal transduction system VarS/VarA is not well understood. This pathway, whic ...

2022

Human commensal gut Proteobacteria withstand type VI secretion attacks through immunity protein-independent mechanisms

Melanie Blokesch, Sandrine Stutzmann, Candice Stoudmann, Nicolas Olmo Flaugnatti, Leonardo Filipe Lemos Rocha, Nina Vesel, Sandrine Natacha Isaac, Thibault Géry L Sana

While the major virulence factors for Vibrio cholerae, the cause of the devastating diarrheal disease cholera, have been extensively studied, the initial intestinal colonization of the bacterium is not well understood because non-human adult animals are re ...

Nature Research2021

A Vibriophage Takes Antirepression to the Next Level

Melanie Blokesch, Leonardo Filipe Lemos Rocha

Since its isolation by Esther Lederberg, phage lambda and its repressor protein CI have contributed substantially to the advancement of molecular biology. In this issue of Cell Host & Microbe, Silpe et al. (2020) characterize the antirepressor Qtip of Vibr ...

Elsevier2020

Targeting liver stage malaria with metformin

Leonardo Filipe Lemos Rocha

Despite an unprecedented 2 decades of success, the combat against malaria - the mosquito-transmitted disease caused by Plasmodium parasites - is no longer progressing. Efforts toward eradication are threatened by the lack of an effective vaccine and a rise ...

2019